Literature DB >> 30009947

Increased choriocapillaris vessel density in amblyopic children: a case-control study.

Enrico Borrelli1, Marcela Lonngi2, Siva Balasubramanian3, Tudor C Tepelus3, Elmira Baghdasaryan3, Stacy L Pineles4, Federico G Velez5, David Sarraf6, SriniVas R Sadda3, Irena Tsui7.   

Abstract

PURPOSE: To investigate the choriocapillaris in children with amblyopia, using optical coherence tomography angiography (OCT-A).
METHODS: Patients with amblyopia and age-matched controls were prospectively imaged using OCT-A. On OCT-A, the choriocapillaris measures 30 μm starting 31 μm posterior to the retinal pigment epithelium. The section of choriocapillaris under superficial retinal vessels was excluded from analysis to avoid shadowing or projection artifacts. The main outcome measure was choriocapillaris vessel density. Secondary outcome measures were foveal macular thickness and parafoveal macular thickness.
RESULTS: A total of 20 eyes of 16 patients with amblyopia and 25 eyes of 25 controls were included. Mean age of amblyopic subjects was 7.6 ± 3.6 years; of controls, 9.3 ± 2.2 years (P = 0.10). Mean refractive error of subjects was 4.3 ± 6.2 D; of controls, 0.0 ± 1.6 D (P = 0.004). Mean choriocapillaris vessel density was 74.8 ± 5.8 in the amblyopic group and 71.1 ± 3.6 in the control group, which was significant even after adjusting for age and refractive error (P = 0.012). There was no difference between groups in foveal macular thickness or parafoveal macular thickness; however, outer parafoveal macular thickness (the inner boundary of the inner nuclear layer to the retinal pigment epithelium outer boundary) was significantly greater in amblyopic eyes than in control eyes, even after adjusting for age and refractive error (203 ± 11 μm and 189 ± 12 μm, resp. [P = 0.014]).
CONCLUSIONS: In our study cohort, amblyopic eyes were found to have increased choriocapillaris vessel density as well as a greater outer parafoveal macular thickness, which may be due to alterations in outer retinal maturation.
Copyright © 2018 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30009947     DOI: 10.1016/j.jaapos.2018.04.005

Source DB:  PubMed          Journal:  J AAPOS        ISSN: 1091-8531            Impact factor:   1.220


  6 in total

1.  Reply to the letter to the editor: Multifocal electroretinography in amblyopia.

Authors:  Christiane Al-Haddad; Alaa Bou Ghannam; Elza Rachid
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-03-28       Impact factor: 3.117

Review 2.  Optical coherence tomography angiography-derived flow density: a review of the influencing factors.

Authors:  Viktoria C Brücher; Jens J Storp; Nicole Eter; Maged Alnawaiseh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-12-09       Impact factor: 3.117

3.  Association of Optical Coherence Tomography Angiography Metrics With Detection of Impaired Macular Microvasculature and Decreased Vision in Amblyopic Eyes: The Hong Kong Children Eye Study.

Authors:  Emily S Wong; Xiu-Juan Zhang; Nan Yuan; Jian Li; C P Pang; Lijia Chen; Clement C Tham; Carol Y Cheung; Jason C Yam
Journal:  JAMA Ophthalmol       Date:  2020-08-01       Impact factor: 7.389

4.  Evaluation of the different thresholding strategies for quantifying choriocapillaris using optical coherence tomography angiography.

Authors:  Rita Laiginhas; Diogo Cabral; Manuel Falcão
Journal:  Quant Imaging Med Surg       Date:  2020-10

5.  Abnormal Outer Choroidal Vasculature in Amblyopia.

Authors:  Noriko Terada; Manabu Miyata; Yuki Muraoka; Masayuki Hata; Masahiro Fujimoto; Satoshi Yokota; Hideo Nakanishi; Kenji Suda; Munemitsu Yoshikawa; Sotaro Ooto; Hiroshi Ohtsuki; Akitaka Tsujikawa
Journal:  J Ophthalmol       Date:  2019-01-10       Impact factor: 1.909

6.  Comparison of optical coherence tomography measurements between high hyperopic and low hyperopic children.

Authors:  Funda Dikkaya; Sevil Karaman Erdur
Journal:  Ther Adv Ophthalmol       Date:  2020-01-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.